Concepedia

Publication | Open Access

Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: Multicentre, open-label, phase II safety study

DOIFull Paper Access

254

Citations

17

References

2013

Year

Jordi Bruix, Won Young Tak, Antonio Gasbarrini, Armando Santoro, M. Colombo, Ho-Yeong Lim, Vincenzo Mazzaferro, Reiner Wiest, María Reig, Luigi Bolondi
European Journal of Cancer

References

YearCitations

Page 1